Home > Boards > US Listed > Biotechs > Apellis Pharmaceuticals (APLS)

First! Holding $40 2/21 call... waiting on trial results!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ComptonBrosInc Member Profile
 
Followed By 7
Posts 276
Boards Moderated 0
Alias Born 03/10/13
160x600 placeholder
Apellis Provides 24-Month Update from Phase 1b Study of Pegcetacoplan in Patients with Geographic Atrophy GlobeNewswire Inc. - 4/13/2021 7:00:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/9/2021 4:05:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/29/2021 4:59:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/19/2021 5:58:47 PM
Apellis and Sobi: The New England Journal of Medicine Publishes Phase 3 PEGASUS Study Results Comparing Pegcetacoplan to Ecul... GlobeNewswire Inc. - 3/17/2021 5:48:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/17/2021 4:17:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/11/2021 7:31:13 AM
Apellis Announces Two New Publications from the Positive Phase 2 FILLY Study Evaluating Pegcetacoplan in Geographic Atrophy GlobeNewswire Inc. - 3/10/2021 9:15:00 AM
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 3/5/2021 4:05:00 PM
Apellis Pharma halts Phase 1/2 trial for APL-9 in severe COVID-19 Seeking Alpha - 3/4/2021 4:37:38 PM
Apellis Provides Update on APL-9 for Severe COVID-19 GlobeNewswire Inc. - 3/4/2021 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/3/2021 4:08:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/3/2021 4:04:30 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 2/25/2021 4:46:37 PM
Apellis Pharmaceuticals EPS beats by $1.38, beats on revenue Seeking Alpha - 2/25/2021 4:02:06 PM
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results GlobeNewswire Inc. - 2/25/2021 4:01:00 PM
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 2/22/2021 8:00:00 AM
Apellis Pharmaceuticals to Hold Fourth Quarter and Full Year 2020 Earnings Conference Call on February 25, 2021 GlobeNewswire Inc. - 2/18/2021 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/17/2021 4:13:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/17/2021 4:12:18 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 4:23:24 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 4:19:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2021 4:19:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2021 4:17:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2021 4:15:50 PM
ComptonBrosInc   Monday, 12/30/19 11:09:23 PM
Re: None
Post # of 4 
First! Holding $40 2/21 call... waiting on trial results!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2021 InvestorsHub.com, Inc.
Consent Preferences




Ticker News is disabled